Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with PHVS: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
PHVS
Pharvaris N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MNPR
2
AZN
AstraZeneca
supplier
—
NorthStar
unlisted
supplier
Shared
0
No shared counterparties.
Only PHVS
1
—
Brain
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
MNPR
Monopar Therapeutics
Change
68.87
▲
+3.91%
Mkt cap
$444.9M
PHVS
Pharvaris N.V.
Change
35.21
▲
+5.00%
Regular session
Nov 3 '26
Mkt cap
$2.2B
vs
Compare
Regular session
Nov 3 '26
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
68.87
▲
+3.91%
Price
35.21
▲
+5.00%
$444.9M
Mkt cap
$2.2B
Change
Change
MNPR
68.87
▲
+3.91%
vs
PHVS
35.21
▲
+5.00%
Regular session
Nov 3 '26